An intronic polymorphism of <i>NFATC1</i> gene shows a risk association with biopsy-proven acute rejection in renal transplant recipients.

导出 LinkOut

翻译打印收藏纠错

第一作者： Zijie,Wang

第一单位： Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.

作者： Zijie,Wang ^[1] ; Hengcheng,Zhang ^[1] ; Haiwei,Yang ^[1] ; Ming,Zheng ^[1] ; Miao,Guo ^[2] ; Hao,Chen ^[1] ; Li,Sun ^[1] ; Zhijian,Han ^[1] ; Jun,Tao ^[1] ; Xiaobing,Ju ^[1] ; Ruoyun,Tan ^[1] ; Ji-Fu,Wei ^[2] ; Min,Gu ^[1]

作者单位： Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. ^[1] Research Division of Clinical Pharmacology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. ^[2]

关键词 NFATC1 biopsy-proven acute rejection (BPAR)kidney transplantation single nucleotide polymorphisms (SNPs)

DOI 10.21037/atm.2020.01.61

PMID 32309358

发布时间 2022-04-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Annals of translational medicine

2020年8卷5期

211页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

An intronic polymorphism of <i>NFATC1</i> gene shows a risk association with biopsy-proven acute rejection in renal transplant recipients.

Annals of translational medicine

相似文献

Annals of translational medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

An intronic polymorphism of <i>NFATC1</i> gene shows a risk association with biopsy-proven acute rejection in renal transplant recipients.

Annals of translational medicine

相似文献

Annals of translational medicine

相关期刊

检索历史清除